MET and familial pancreatic carcinoma: For examples, a previous report showed that c-Met/hepatocyte growth factor receptor and PDL1 expression in circulating EXs in peripheral blood could be used as a diagnostic and prognostic marker for pancreatic cancer [61], but more accurate approaches for disease diagnosis must be developed.